Aberrant expression of GAS1 reduces tumorigenicity in human brain tumor-initiating cells [41], while downregulation of GAS1 expression is a potential biomarker of clear cell renal cell carcinoma [42]. The gene discussed is GAS1; the disease is clear cell renal carcinoma.